| Document Date: 2013-01-14 00:13:23
Open Document File Size: 3,05 MBShare Result on Facebook
Country United States / / Facility Community Research Yale University / / IndustryTerm occasional portal / HCV Treatment / / MedicalCondition Hepatic fibrosis / HCV RNA 6 / Metabolic syndrome / HIV Infection Opportunistic Infections EtOH IDU HCV NRTIs HBV NNRTI HAV PIs Immune Reconstitution Fatty Liver Disease / Liver fibrosis / insulin resistance / hepatitis-related cirrhosis / compensated cirrhosis / obesity / HIV / HBV / Epidemic / severe Hepatocellular carcinoma / infection / Viral Hepatitis / Hepatocellular carcinoma / hepatitis / Progress Fibrosis / liver disease / chronic HCV / Moderate Severe Cirrhosis / viral hepatitis liver disease / Cirrhosis / Schistosomiasis / Fibrosis / Decreased cirrhosis / HCV / / MedicalTreatment Blood transfusion / / Organization World Health Organization / Yale University / / Person Frederick L. Altice / / Position Professor of Medicine / Epidemiology and Public Health Director / / Product GT Medication / / Technology ultrasound / transplantation / /
SocialTag |
Overview of HCV and Strategies to Treat HCV Among Patients With Substance Use Disorders Frederick L. Altice, M.D., M.A. Professor of Medicine, Epidemiology and Public Health